NASDAQ:ENLV

Enlivex Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy ENLV

*Your capital is at risk

$0.85

-0.0135 (-1.56%)

At Close: Jun 02, 2026

Currently predicting for Thu, 4 Jun 2026

ENLV Prediction Chart

ENLV Predictions History

Latest community submissions for ENLV.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Feb 9, 2021	$21.79 -9.21%	$24.00	X	90.79%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ENLV with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ENLIVEX THERAPEUTICS LTD.

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel....

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by